Clinical Trials Logo

Ultrasonography clinical trials

View clinical trials related to Ultrasonography.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04246411 Withdrawn - Child Clinical Trials

Ultrasound vs. Auscultation for Optimal Depth of the Cuffless RAE Tube

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to compare the ultrasound-guidance versus auscultation to confirm optimal insertion depth of the cuffless oral Ring-Adair-Elwyn (RAE) endotracheal tube in pediatric patients undergoing general anesthesia.

NCT ID: NCT03058614 Withdrawn - Ultrasonography Clinical Trials

Contrast-enhanced Ultrasound Versus CT Scan for Kidney Stone Patient Management

CEUS
Start date: June 30, 2017
Phase: Phase 2
Study type: Interventional

This study will be a randomized controlled study comparing the use of two clinical management strategies in nephrostomy tube management following percutaneous nephrolithotomy (PCNL). The first strategy entails using contrast-enhanced ultrasound (CEUS) to evaluate the renal collecting system (1). This is a new imaging approach applying ultrasound machines with special software in combination with intraluminal ultrasound contrast agent (Lumason) injection, which is an FDA-approved ultrasound contrast agent (2). The second strategy is a nephrostomy tube capping trial combined with low dose non-contrast computed tomography (CT) scan, one of the most frequently utilized clinical management strategies currently used in clinical practice (3).

NCT ID: NCT01071733 Withdrawn - Ultrasonography Clinical Trials

Fracture Evaluated in Emergency Room by Ultra Sound

FREEUS
Start date: December 2009
Phase: N/A
Study type: Observational

The purpose of this study is to compare fracture diagnostic, conventional x-ray versus ultrasound.

NCT ID: NCT01063686 Withdrawn - Ultrasonography Clinical Trials

The Cervical Cap in the Diagnosis of Rupture of Membranes in the Second Trimester

Start date: n/a
Phase: N/A
Study type: Interventional

Early preterm premature rupture of membranes (PPROM) complicates 0.7% of pregnancies. When PPROM occurs before the 24th week,the risk of fetal and neonatal death is 70%. There is also a high risk of neonatal and maternal morbidity. When the diagnosis of PPROM is uncertain by physical examination, additional tests are needed. These tests have false positive and false negative rates. The gold standard for diagnosing PPROM is amniocentesis and dye test. This procedure has a risk of infection and abortion.Our hypothesis is that by using a cervical cap for 6 hours and repeated ultrasound exams we can diagnose or rule out PPROM in cases which are uncertain. Our study group will be pregnant women gestational age 14-23, suspected of having PPROM.